[Remarkable evolution of hepatic, pleural and pulmonary amoebiasis: a case report].
Entamoeba histolytica, is a human pathogen which is endemic in tropical areas. The most common extra-intestinal locations for disease after the liver are pleural and pulmonary. Although the outcome of pleural and pulmonary amoebiasis is generally favourable, it is important to note that a significant proportion of patients do develop pleural and pulmonary after-effects. We report a case of pleural and pulmonary amoebiasis where the evolution of a massive pleural effusion and 3 associated liver abscesses was spectacular. The surgical management of pleural, pulmonary and liver amoebiasis is discussed.
Horo
K
K
Service de Pneumologie, CHU de Cocody, Côte d'Ivoire. kigninlmanh@yahoo.fr
N'gom
A
A
Aké
C
C
Kouassi
B A
BA
Godé
V C
VC
Ahui
B J-M
BJ
Fotso
S
S
Ouattara
K
K
Kouassi
B
B
Aka-Danguy
E
E
D000328:Adult; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D004748:Entamoeba histolytica / Q000302:isolation & purification; D004749:Entamoebiasis / Q000175:diagnosis* / Q000188:drug therapy / Q000469:parasitology; D006801:Humans; D008101:Liver Abscess, Amebic / Q000175:diagnosis* / Q000188:drug therapy / Q000469:parasitology; D008174:Lung Diseases, Parasitic / Q000175:diagnosis* / Q000188:drug therapy / Q000469:parasitology; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D010996:Pleural Effusion / Q000175:diagnosis / Q000469:parasitology*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000981:Antiprotozoal Agents; D008795:Metronidazole